Современные возможности терапии угрозы преждевременных родов

1. Акушерство: Национальное руководство. Под ред. В.И.Кулакова, Г.М.Савельевой, В.Е.Радзинского, Э.К.Айламазян
2. Cordero L, Nankervis CA, Gardner D, Giannone, PJ. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants. J Perinatol 2007; 27: 22.
3. Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol 2007; 197: 486.
4. Groom KM, Shennan AH, Jones BA et al. TOCOX-A randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG 2005; 112: 725.
5. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor. Obstet Gynecol 2003; 101: 1039.
6. Lyell DJ, Pullen K, Campbell L et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol 2007; 110: 61.
7. Mittendorf R, Dambrosia J, Pryde PG et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111.
8. Marret S, Marpeau L, Zupan-Simunek V et al. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*. BJOG 2007; 114: 310.
9. Stika CS, Gross GA, Leguizamon G et al. A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol 2002; 187: 653. 
10. Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020.
11. Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med 2007; 357: 477.
12. Hayes E, Moroz L, Pizzi L, Baxter J. A cost decision analysis of 4 tocolytic drugs. Am J Obstet Gynecol 2007; 197: 383.
13. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005; :CD001992.
14. King JF, Flenady VJ, Papatsonis DN et al. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003; :CD002255. 
15. Lyell DJ, Pullen K, Campbell L et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor. Obstet Gynecol 2007; 110: 61.
16. van Veen AJ, Pelinck MJ, van Pampus MG, Erwich JJ. Severe hypotension and fetal death due to tocolysis with nifedipine. BJOG 2005; 112: 509.
17. Thornton J. The quality of randomised trials of tocolysis. BJOG 2006; 113 (Suppl. 3): 93.
18. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007; 114: 289.
19. Yost NP, Bloom SL, McIntire DD, Leveno KJ. Hospitalization for women with arrested preterm labor. Obstet Gynecol 2005; 106: 14.

________________________________________________

1. Акушерство: Национальное руководство. Под ред. В.И.Кулакова, Г.М.Савельевой, В.Е.Радзинского, Э.К.Айламазян
2. Cordero L, Nankervis CA, Gardner D, Giannone, PJ. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants. J Perinatol 2007; 27: 22.
3. Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol 2007; 197: 486.
4. Groom KM, Shennan AH, Jones BA et al. TOCOX-A randomised, double-blind, placebo-controlled trial of rofecoxib (a COX-2-specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG 2005; 112: 725.
5. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor. Obstet Gynecol 2003; 101: 1039.
6. Lyell DJ, Pullen K, Campbell L et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol 2007; 110: 61.
7. Mittendorf R, Dambrosia J, Pryde PG et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111.
8. Marret S, Marpeau L, Zupan-Simunek V et al. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*. BJOG 2007; 114: 310.
9. Stika CS, Gross GA, Leguizamon G et al. A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol 2002; 187: 653. 
10. Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020.
11. Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med 2007; 357: 477.
12. Hayes E, Moroz L, Pizzi L, Baxter J. A cost decision analysis of 4 tocolytic drugs. Am J Obstet Gynecol 2007; 197: 383.
13. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005; :CD001992.
14. King JF, Flenady VJ, Papatsonis DN et al. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003; :CD002255. 
15. Lyell DJ, Pullen K, Campbell L et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor. Obstet Gynecol 2007; 110: 61.
16. van Veen AJ, Pelinck MJ, van Pampus MG, Erwich JJ. Severe hypotension and fetal death due to tocolysis with nifedipine. BJOG 2005; 112: 509.
17. Thornton J. The quality of randomised trials of tocolysis. BJOG 2006; 113 (Suppl. 3): 93.
18. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007; 114: 289.
19. Yost NP, Bloom SL, McIntire DD, Leveno KJ. Hospitalization for women with arrested preterm labor. Obstet Gynecol 2005; 106: 14.

И.О.Макаров, Е.И.Боровкова, Н.А.Шешукова

Кафедра акушерства и гинекологии ФППОВ (зав. – проф. И.О.Макаров) Первого МГМУ им. И.М.Сеченова